Our Joint Coordination Group is a roundtable of independent institutions who all have a vested interest in seeing CEPI’s vaccines successfully developed and deployed in an outbreak.

These independent institutions play a role in various elements of the vaccine development lifecycle, from vaccine research and development all the way through to deploying vaccines during an outbreak. 

Members of our Joint Coordination Group come together to discuss how we can best enhance our efforts to deliver and deploy vaccines by addressing challenges related to the research and development, regulation, stockpiling, and delivery of these products. In particular, while the group focuses on advancing our vaccine portfolio, its work also informs the broader field of vaccine development and preparedness.

Members also have a role in planning for rapid response to a priority pathogen or an unknown pathogen. Our Joint Coordination Group consists of 10 to 15 member organisations, which in turn appoint individuals to represent them at meetings.

From time to time, the group may choose to invite other organisations and experts to participate in meetings. 

The current members of the Joint Coordination Group include: WHO, GAVI, EMA, FDA, MSF, UNICEF, IFRC, NIBSC, and Wellcome